MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

A

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

Search

Charles River Laboratories International Inc

Fechado

SetorSaúde

219.46 -0.11

Visão Geral

Variação de preço das ações

24h

Atual

Mín

219.46

Máximo

219.46

Indicadores-chave

By Trading Economics

Rendimento

2.9M

56M

Vendas

-27M

1B

EPS

2.43

Margem de lucro

5.529

Funcionários

18,700

EBITDA

-23M

198M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

-3.14% downside

Dividendos

By Dow Jones

Próximos Ganhos

18 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

2B

11B

Abertura anterior

219.57

Fecho anterior

219.46

Sentimento de Notícias

By Acuity

46%

54%

162 / 361 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Charles River Laboratories International Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de jan. de 2026, 16:17 UTC

Aquisições, Fusões, Aquisições de Empresas

Zurich Insurance Makes $10 Billion Bid for U.K. Specialist Insurer Beazley -- Update

19 de jan. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Europe Relations -- Market Talk

19 de jan. de 2026, 23:42 UTC

Conversa de Mercado

Gold Edges Lower on Likely Technical Correction -- Market Talk

19 de jan. de 2026, 22:29 UTC

Conversa de Mercado

China Infant Formula Market May Hold Up Despite Steep Drop in Births -- Market Talk

19 de jan. de 2026, 22:29 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

19 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

19 de jan. de 2026, 21:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

19 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

19 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

19 de jan. de 2026, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

19 de jan. de 2026, 17:09 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

19 de jan. de 2026, 17:09 UTC

Conversa de Mercado

Copper Rises in Spite of Softer Dollar, Trade Concerns -- Market Talk

19 de jan. de 2026, 16:18 UTC

Conversa de Mercado

New Zealand Dollar Could Recover Against Swedish Krona -- Market Talk

19 de jan. de 2026, 16:12 UTC

Conversa de Mercado

Norwegian Krone's Recent Gains Are Unlikely to Last -- Market Talk

19 de jan. de 2026, 16:06 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Deal Completion Subject to Customary Closing Conditions and Expected to Close in Around Two Months

19 de jan. de 2026, 16:04 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Both Parties Aim to Set Up Strategic Cooperation in the Retail Sector

19 de jan. de 2026, 16:03 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH, CTG Duty-Free Also Entered Into a MoU

19 de jan. de 2026, 16:02 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Subscription to Be Made Upon Completion of Transaction

19 de jan. de 2026, 16:00 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Capital Increase by Subscribing to Newly Issued H-shares Listed in Hong Kong

19 de jan. de 2026, 16:00 UTC

Conversa de Mercado

Term Premium on U.S. Treasurys Looks Too Low, Says Pictet AM -- Market Talk

19 de jan. de 2026, 15:58 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH and the Miller Family Will Participate in a Capital Increase of CTG DutyFree

19 de jan. de 2026, 15:57 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: DFS Will Continue to Operate Its Other Luxury Travel Retail Operations Worldwide

19 de jan. de 2026, 15:57 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Proceeds of Transaction Will Be Paid in Cash

19 de jan. de 2026, 15:56 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: CTG Duty-Free Will Run the Acquisition Through Its Subsidiary China Duty Free International Limited

19 de jan. de 2026, 15:53 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: Intangible Assets Include a Series of DFS Brands and IP for Exclusive Use in Greater China

19 de jan. de 2026, 15:52 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: CTG Duty-Free to Acquire the DFS Retail Stores in Hong Kong and Macau and Intangible Assets

19 de jan. de 2026, 15:51 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH: DFS, CTG Duty-Free Reach Definitive Pact for CTG Duty-Free to Buy DFS' Travel Retail Unit in Hong Kong and Macau and Intangible Assets in Greater China

19 de jan. de 2026, 15:39 UTC

Conversa de Mercado

Canadian Dollar's Underperformance Looks Overstretched -- Market Talk

19 de jan. de 2026, 15:37 UTC

Conversa de Mercado

Bank of Canada Could Consider Cutting Rates if Underlying Inflation Slows Further -- Market Talk

Comparação entre Pares

Variação de preço

Charles River Laboratories International Inc Previsão

Preço-alvo

By TipRanks

-3.14% parte inferior

Previsão para 12 meses

Média 212.8 USD  -3.14%

Máximo 265 USD

Mínimo 170 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para Charles River Laboratories International Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

12 ratings

8

Comprar

4

Manter

0

Vender

Pontuação Técnica

By Trading Central

117.16 / 144.77Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Weak Bullish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

162 / 361 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Charles River Laboratories International Inc

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
help-icon Live chat